Immunization, Hib3 in Türkiye
Türkiye: Immunization, Hib3 was 99.0% in 2024. ▲ Rising
Immunization, Hib3 in Türkiye, 2007–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
The most recent figure for immunization, hib3 in Türkiye is 99.0%, measured in 2024. That is the highest value across all 18 years on record.
That represents a change of up 3.1% over ten years.
Over the whole period, immunization, hib3 in Türkiye peaked at 99.0% in 2019 and was at its lowest, 76.0%, in 2007.
That places Türkiye 1st out of 191 countries with data for 2024, putting it in the top 10%.
The long-run direction has been consistently rising across the 18 years of available data.
Immunization, Hib3 in Türkiye, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 2007 | 76.0% | — |
| 2008 | 96.0% | +26.3% |
| 2009 | 96.0% | +0.0% |
| 2010 | 97.0% | +1.0% |
| 2011 | 97.0% | +0.0% |
| 2012 | 97.0% | +0.0% |
| 2013 | 98.0% | +1.0% |
| 2014 | 96.0% | -2.0% |
| 2015 | 97.0% | +1.0% |
| 2016 | 98.0% | +1.0% |
| 2017 | 96.0% | -2.0% |
| 2018 | 98.0% | +2.1% |
| 2019 | 99.0% | +1.0% |
| 2020 | 98.0% | -1.0% |
| 2021 | 95.0% | -3.1% |
| 2022 | 99.0% | +4.2% |
| 2023 | 99.0% | +0.0% |
| 2024 | 99.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 89.3% | 76.0% | 96.0% | 3 |
| 2010s | 97.3% | 96.0% | 99.0% | 10 |
| 2020s | 98.0% | 95.0% | 99.0% | 5 |
Countries ranked near Türkiye
- 1 Antigua and Barbuda 99.0% compare
- 1 Brunei Darussalam 99.0% compare
- 1 Costa Rica 99.0% compare
- 1 Cuba 99.0% compare
- 1 Greece 99.0% compare
- 1 Hungary 99.0% compare
- 1 Jamaica 99.0% compare
- 1 Korea, Democratic People's Republic of 99.0% compare
- 1 Kuwait 99.0% compare
- 1 Luxembourg 99.0% compare
- 1 Maldives 99.0% compare
- 1 Monaco 99.0% compare
- 1 Oman 99.0% compare
- 1 Palau 99.0% compare
- 1 Portugal 99.0% compare
- 1 Saint Lucia 99.0% compare
- 1 Saint Vincent and the Grenadines 99.0% compare
- 1 Tonga 99.0% compare
More health data for Türkiye
- Un projection of annual infant deaths, annual growth rate -1.72 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5275 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,582 deaths per 1,000 people (2090)
- Number of infants who die before age 1 858 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 1 (2025)
- Population ages 00-04, female, annual growth rate -3.16 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0298 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.94 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is immunization, hib3 in Türkiye?
- Immunization, hib3 in Türkiye was 99.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Türkiye?
- The highest recorded value was 99.0% in 2019.
- What is the lowest immunization, hib3 recorded in Türkiye?
- The lowest recorded value was 76.0% in 2007.
- How does Türkiye rank for immunization, hib3?
- Türkiye ranks 1st out of 191 countries with data for 2024.
- Is immunization, hib3 rising or falling in Türkiye?
- Over the last ten years it is up 3.1%. The long-run trend across the full record is rising.
- Where does this Türkiye data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.